Skip to main content

mHealth-Supported Intervention Boosts Physical Activity in Adults With Newly Diagnosed Diabetes

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on April 8, 2025.

via HealthDay

TUESDAY, April 8, 2025 -- A mobile health (mHealth)-supported home-delivered physical activity (PA) intervention is feasible and effective at promoting sustained, purposeful exercise in adults with newly diagnosed diabetes, according to a study published online March 26 in BMJ Open.

Katie Hesketh, Ph.D., from University of Birmingham in the United Kingdom, and colleagues assessed the feasibility of an mHealth-supported home-delivered PA intervention (MOTIVATE-T2D) in adults with recently diagnosed type 2 diabetes. The analysis included 125 participants randomly assigned (1:1) to intervention (MOTIVATE-T2D) or active control groups.

The researchers found that MOTIVATE-T2D participants were more likely to start (odds ratio [OR], 10.4) and maintain purposeful exercise at six (OR, 7.1) and 12 months (OR, 2.9). An exploratory analysis showed a potential effect in favor of MOTIVATE-T2D, including proposed primary outcomes hemoglobin A1c (HbA1c) and systolic blood pressure in a future randomized controlled trial (between-group mean differences: HbA1c at six months, −5 percent change from baseline; HbA1c at 12 months, −2 percent change from baseline; systolic blood pressure at six months, −1 mm Hg; systolic blood pressure at 12 months, −4 mm Hg).

"The results from this trial suggest that the MOTIVATE-T2D approach of using biometrics from wearable technologies to support a home-delivered, personalized behavioral counseling service was promising for the promotion, uptake, and adherence to purposeful exercise in people with newly diagnosed type 2 diabetes," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Diabetes Risk Commonly Clustered Within Households

TUESDAY, Aug. 19, 2025 -- Diabetes risk is commonly clustered within households, according to a study scheduled to be presented at the annual meeting of the European Association...

Saliva Insulin Can Differentiate Hyperinsulinemia in Normoglycemic People

MONDAY, Aug. 18, 2025 -- Saliva insulin can differentiate between normal and hyperinsulinemic responses among normoglycemic adults with different body mass index (BMI) classes...

26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024

THURSDAY, Aug. 14, 2025 -- In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.